Results of the Cox proportional hazard models of the walking speed for outcomes
| Outcomes . | No. of events/cases . | HR (95% CI) . | P value . |
|---|---|---|---|
| Combined events (per 0.1 m/s increase) | 429/1391 (30.8%) | 0.951 (0.912–0.992) | 0.035 |
| All-cause death (per 0.1 m/s increase) | 134/1391 (9.6%) | 0.924 (0.853–0.998) | 0.048 |
| Outcomes . | No. of events/cases . | HR (95% CI) . | P value . |
|---|---|---|---|
| Combined events (per 0.1 m/s increase) | 429/1391 (30.8%) | 0.951 (0.912–0.992) | 0.035 |
| All-cause death (per 0.1 m/s increase) | 134/1391 (9.6%) | 0.924 (0.853–0.998) | 0.048 |
Adjustment variables used for combined events and all-cause death were age; sex; body mass index; New York Heart Association class III/IV; systolic blood pressure; left ventricular ejection fraction; current smoking status; history of heart failure (whether or not a history of hospitalization); hypertension, diabetes, coronary artery disease, chronic obstructive pulmonary disease, atrial fibrillation, and stroke; eGFR; haemoglobin; serum sodium level; serum albumin; log-transformed BNP; prescription of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, beta-blocker, and mineralocorticoid receptor antagonist at admission; and physical activity level before admission.
CI, confidence interval; HR, hazard ratio.
Results of the Cox proportional hazard models of the walking speed for outcomes
| Outcomes . | No. of events/cases . | HR (95% CI) . | P value . |
|---|---|---|---|
| Combined events (per 0.1 m/s increase) | 429/1391 (30.8%) | 0.951 (0.912–0.992) | 0.035 |
| All-cause death (per 0.1 m/s increase) | 134/1391 (9.6%) | 0.924 (0.853–0.998) | 0.048 |
| Outcomes . | No. of events/cases . | HR (95% CI) . | P value . |
|---|---|---|---|
| Combined events (per 0.1 m/s increase) | 429/1391 (30.8%) | 0.951 (0.912–0.992) | 0.035 |
| All-cause death (per 0.1 m/s increase) | 134/1391 (9.6%) | 0.924 (0.853–0.998) | 0.048 |
Adjustment variables used for combined events and all-cause death were age; sex; body mass index; New York Heart Association class III/IV; systolic blood pressure; left ventricular ejection fraction; current smoking status; history of heart failure (whether or not a history of hospitalization); hypertension, diabetes, coronary artery disease, chronic obstructive pulmonary disease, atrial fibrillation, and stroke; eGFR; haemoglobin; serum sodium level; serum albumin; log-transformed BNP; prescription of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, beta-blocker, and mineralocorticoid receptor antagonist at admission; and physical activity level before admission.
CI, confidence interval; HR, hazard ratio.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
